Iñaki Eguren-Santamaría

14PUBLICATIONS
54CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsInstruments and techniquesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 16, 2026
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.

Miguel F Sanmamed, Carlos E de Andrea, David Ruiz-Guillamon

|Oct 29, 2025
Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic.

Iñaki Eguren-Santamaria, Ignacio Melero, Inmaculada Rodríguez

|Nov 12, 2024
Targeting T-Cell Costimulation to the Surface of Tumor Cells.

Iñaki Eguren-Santamaría, Miguel F Sanmamed, Paula Molero-Glez

|Sep 07, 2024
MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers.

Iñaki Eguren-Santamaria, Eva Fernández de Piérola, Gracián Camps

|Apr 17, 2024
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.

Alvaro Teijeira, Saray Garasa, Maria C Ochoa

|Sep 01, 2023
Druggable Targets in Cytokine Release Syndromes.

Carlos Luri-Rey, Iñaki Eguren-Santamaria, Ignacio Matos

Pageof 3

Frequent Collaborators

12 joint publications

Ignacio Melero

9 joint publications

Pedro Berraondo

7 joint publications

Alvaro Teijeira

7 joint publications

Miguel F Sanmamed